Tesla, the No. 1 stock traded Tuesday, closed down 1.64 percent to $29.46 billion. Tesla will sell its Chinese-made Model 3 and Model Y cars in Canada, according to the company's website, confirming that the electric carmaker has completed its first shipments from its Shanghai factory to North America.
Tesla's website shows that both the rear-wheel-drive Model Y and the long-range all-wheel-drive Model 3 are available for immediate delivery in British Columbia, with codes indicating they were built at Tesla's Gigafactory in Shanghai.
Asked if India was an "interesting" location for a factory for Tesla, Musk reportedly said "absolutely."
No. 2 Nvidia closed down 1.57 percent on $10.96 billion. Nvidia is reportedly integrating AI enterprise software into Microsoft's Azure.
No. 3 Microsoft closed down 1.84 percent on $9.51 billion. Microsoft's annual Build developer conference has officially kicked off. Microsoft CEO Nadella said the company will announce more than 50 product updates. Nadella claims Windows' "AI moment" has arrived -- Windows Copilot.
No. 4 Apple fell 1.52 percent to $8.47 billion. Apple's World Wide Developers Conference 2023 kicks off on June 5.
No. 8 Google Class A shares (GOOGL) closed down 1.99% on $4.17 billion. No. 10 Google (GOOG) closed down 2.05% on $3.02 billion. Google on Tuesday unveiled an artificial intelligence (AI) tool to help marketers create ads that automatically generate highly relevant text and images based on simple prompts.
Google is clearly taking this seriously. "Usher in a new era of AI advertising" is the title of the company's latest blog post.
No. 11 Pfizer rose 2.3 percent to $2.93 billion. According to the results of a peer-reviewed Phase II clinical trial published on the JAMA Network on May 22, a new oral small-molecule weight loss drug (danuglipron) under development by Pfizer is as effective as current market leaders such as Novo Nordisk's "star treatments" Ozempic and Wegovy (Smeiglutide, semaglutide had similar weight loss and acted more quickly.
No. 15 Palantir closed up 6.76 percent on $1.9 billion. Cathy Wood's ARK Fund, a prominent investor, continued to increase its stake in Palantir on Monday, adding about $4 million worth of the company's stock to its portfolio of funds. The ARK Innovation ETF bought an additional 243,158 Palantir shares, worth about $2.9 million, based on Monday's closing price of $11.84. ARK Fintech ETF added 54,250 shares of Palantir stock worth about $642,000. The ARK Next Generation ETF added 42,162 Palantir shares worth just under $500,000.
No. 16 Eli Lilly fell 2.48 percent on $1.89 billion. Eli Lilly and Company has announced positive results from a phase III clinical trial of the Alzheimer's drug Donabumab. Donabumab slowed cognitive decline in Alzheimer's patients by 35 percent compared with placebo.
Lilly said it would file a marketing application for donabumab with the U.S. Food and Drug Administration this quarter. If approved, Donabumab would be the third monoclonal antibody to treat Alzheimer's disease in the United States. The first two, Aducamizumab and Lencanalizumab, received FDA marketing approval in June 2021 and January of this year, respectively.
No. 18 Chevron gained 2.89 percent to $1.63 billion. Chevron Corp said Monday it will buy shale oil producer PDC Energy for $7.6 billion in a stock and debt deal to expand its U.S. oil and gas operations. The deal values Denver-based PDC at $72 a share, a premium of about 14 per cent to its average share price in the 10 days through Friday. The deal is expected to close by the end of the year, the companies said.
For Chevron, the second-largest US oil company, the deal will increase production, capital expenditure and cash flow in the US. Global energy supplies have been strained by geopolitical tensions following the conflict between Russia and Ukraine last year.
Here are the 20 most actively traded U.S. stocks of the day (by turnover) :
(Screenshot from Sina financial APP - US stock - market sector slide left for more data) Download Sina financial APP
Responsible Editor: Zhang Jun SF065
User comments